Covaxin / BBV152
0 sources
Covaxin / BBV152
Summary
Covaxin / BBV152 has Wikipedia articles in 23 language editions, a strong signal of global cultural recognition.[1]
Key Facts
- Covaxin / BBV152's manufacturer is recorded as Bharat Biotech International[2].
- Covaxin / BBV152's developer is recorded as Bharat Biotech International[3].
- Covaxin / BBV152's developer is recorded as Indian Council of Medical Research[4].
- Covaxin / BBV152's developer is recorded as National Institute of Virology[5].
- Covaxin / BBV152 is a type of COVID-19 vaccine[6].
- Covaxin / BBV152 is a type of inactivated vaccine[7].
- Covaxin / BBV152's Commons category is recorded as Covaxin[8].
- Covaxin / BBV152's country of origin is recorded as India[9].
- Covaxin / BBV152's route of administration is recorded as intramuscular injection[10].
- Covaxin / BBV152's described by source is recorded as Whole-Virion Inactivated SARS-CoV-2 Vaccine (BBV152) for COVID-19 in Healthy Volunteers[11].
- Covaxin / BBV152's described by source is recorded as Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial[12].
- Covaxin / BBV152's vaccine for is recorded as COVID-19[13].
Body
Definition and Type
Recorded subclass of include COVID-19 vaccine[6] and inactivated vaccine[7].
Why It Matters
Covaxin / BBV152 has Wikipedia articles in 23 language editions, a strong signal of global cultural recognition.[1] It is known by 19 alternative names across languages and contexts.[14]